137 related articles for article (PubMed ID: 38644522)
61. Hidradenitis Suppurativa is Associated with Higher Heart Rate but Not Atrial Fibrillation: A Comparative Cross-sectional Study of 462 Individuals with Hidradenitis Suppurativa in Denmark.
Miller IM; Ahlehoff O; Vinding G; Rytgaard H; Mogensen UB; Ring HC; Ellervik C; Jemec GBE
Acta Dermatovenerol Croat; 2018 Dec; 26(4):289-296. PubMed ID: 30665477
[TBL] [Abstract][Full Text] [Related]
62. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
[TBL] [Abstract][Full Text] [Related]
63. Risk of connective tissue disease, morphoea and systemic vasculitis in patients with hidradenitis suppurativa.
Schneeweiss MC; Merola JF; Schneeweiss S; Wyss R; Rosmarin D
J Eur Acad Dermatol Venereol; 2021 Jan; 35(1):195-202. PubMed ID: 32531094
[TBL] [Abstract][Full Text] [Related]
64. Hidradenitis suppurativa and electrocardiographic changes: a cross-sectional population study.
Juhl CR; Miller IM; Jemec GB; Kanters JK; Ellervik C
Br J Dermatol; 2018 Jan; 178(1):222-228. PubMed ID: 28667743
[TBL] [Abstract][Full Text] [Related]
65. Prevalence and comorbidities associated with hidradenitis suppurativa in Korea: a nationwide population-based study.
Lee JH; Kwon HS; Jung HM; Kim GM; Bae JM
J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1784-1790. PubMed ID: 29761904
[TBL] [Abstract][Full Text] [Related]
66. A new T helper 17 cytokine in hidradenitis suppurativa: antimicrobial and proinflammatory role of interleukin-26.
Scala E; Di Caprio R; Cacciapuoti S; Caiazzo G; Fusco A; Tortorella E; Fabbrocini G; Balato A
Br J Dermatol; 2019 Nov; 181(5):1038-1045. PubMed ID: 30829398
[TBL] [Abstract][Full Text] [Related]
67. The prevalence of metabolic syndrome in patients with hidradenitis suppurativa.
Gold DA; Reeder VJ; Mahan MG; Hamzavi IH
J Am Acad Dermatol; 2014 Apr; 70(4):699-703. PubMed ID: 24433875
[TBL] [Abstract][Full Text] [Related]
68. The risk trajectory of different cardiovascular morbidities associated with chronic kidney disease among patients with newly diagnosed diabetes mellitus: a propensity score-matched cohort analysis.
Chao CT; Lee SY; Wang J; Chien KL; Hung KY
Cardiovasc Diabetol; 2021 Apr; 20(1):86. PubMed ID: 33894776
[TBL] [Abstract][Full Text] [Related]
69. Hidradenitis suppurativa and inflammatory bowel disease in a nested case-control study.
Neri B; Mossa M; Salvatori S; Appolloni V; Pensa C; Lambiase S; Lolli E; Calabrese E; Monteleone G; Bianchi L; Campione E; Biancone L
Dig Liver Dis; 2023 Apr; 55(4):490-495. PubMed ID: 36371384
[TBL] [Abstract][Full Text] [Related]
70. Identification of bacterial DNA in the peripheral blood of patients with active hidradenitis suppurativa.
Hispán P; Murcia O; Gonzalez-Villanueva I; Francés R; Giménez P; Riquelme J; Betlloch I; Pascual JC
Arch Dermatol Res; 2020 Mar; 312(2):159-163. PubMed ID: 31422449
[TBL] [Abstract][Full Text] [Related]
71. Hidradenitis suppurativa tarda: defining an understudied elderly population.
van der Weijden DAY; Koerts NDK; van Munster BC; van der Zee HH; Horváth B
Br J Dermatol; 2023 Dec; 190(1):105-113. PubMed ID: 37665963
[TBL] [Abstract][Full Text] [Related]
72. Gallstones are associated with hidradenitis suppurativa: a population-based and hospital-based cross-sectional study from Denmark.
Miller IM; Vindsand Naver A; Mogensen UB; Zarchi K; Ring HC; Ellervik C; Jemec GB
Eur J Gastroenterol Hepatol; 2015 Dec; 27(12):1392-8. PubMed ID: 26426833
[TBL] [Abstract][Full Text] [Related]
73. Somatic and psychiatric comorbidities of hidradenitis suppurativa in children and adolescents.
Tiri H; Jokelainen J; Timonen M; Tasanen K; Huilaja L
J Am Acad Dermatol; 2018 Sep; 79(3):514-519. PubMed ID: 29518461
[TBL] [Abstract][Full Text] [Related]
74. Endocrinologic Aspects of Hidradenitis Suppurativa.
Karagiannidis I; Nikolakis G; Zouboulis CC
Dermatol Clin; 2016 Jan; 34(1):45-9. PubMed ID: 26617357
[TBL] [Abstract][Full Text] [Related]
75. Implications of Hidradenitis Suppurativa Phenotypes in Cardiovascular Risk and Treatment Decisions: A Retrospective Cohort Study.
Cuenca-Barrales C; Montero-Vilchez T; Salvador-Rodríguez L; Sánchez-Díaz M; Arias-Santiago S; Molina-Leyva A
Dermatology; 2021; 237(5):727-732. PubMed ID: 33477150
[TBL] [Abstract][Full Text] [Related]
76. Low referral rate of overweight/obese patients with hidradenitis suppurativa to weight-management services: a missed opportunity?
Khalil N; Hussain K; Patel NP
Clin Exp Dermatol; 2024 Mar; 49(4):383-385. PubMed ID: 38037674
[TBL] [Abstract][Full Text] [Related]
77. Risk of cardiovascular events and mortality among a population-based cohort of immigrants and long-term residents with diabetes: Are all immigrants healthier and if so, for how long?
Okrainec K; Bell CM; Hollands S; Booth GL
Am Heart J; 2015 Jul; 170(1):123-32. PubMed ID: 26093873
[TBL] [Abstract][Full Text] [Related]
78. Association between hidradenitis suppurativa and increased risk of venous thromboembolism: A multicenter retrospective cohort study.
Garate D; Woolridge K; Wilkerson MG; Munoz Gonzalez A
J Am Acad Dermatol; 2024 Jul; 91(1):113-116. PubMed ID: 38460789
[No Abstract] [Full Text] [Related]
79. Association Between Hidradenitis Suppurativa and Metabolic Syndrome: A Systematic Review and Meta-analysis.
Rodríguez-Zuñiga MJM; García-Perdomo HA; Ortega-Loayza AG
Actas Dermosifiliogr (Engl Ed); 2019 May; 110(4):279-288. PubMed ID: 30846164
[TBL] [Abstract][Full Text] [Related]
80. The clinical, biochemical, and ultrasonographic characteristics of patients with hidradenitis suppurativa in Northern Peninsular Malaysia: a multicenter study.
Loo CH; Tan WC; Tang JJ; Khor YH; Manikam MT; Low DE; Chan KH; Chan KH; Teoh YM; Sohot NQA; Tang MM; Chan LC
Int J Dermatol; 2018 Dec; 57(12):1454-1463. PubMed ID: 30182482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
